Altasciences Wins Most Successful Early Phase Research (Preclinical & Phase I) at the 2019 CARE Awards
Altasciences won in the Most Successful Early Phase Research (Preclinical & Phase I) category at the 2019 Clinical and Research Excellence (CARE) Awards. The award win was announced during a ceremony presented by Ben Nemzer at the Hyatt Regency Boston, US on May 2, 2019.
Altasciences Receives CRO Leadership Award in Five Categories
For the 2019 CRO Leadership Awards, Life Science Leader magazine once again teamed up with Industry Standard Research (ISR) to determine the award recipients.
Altasciences Contributes to Positive Top-Line Phase I Results for Chronic Cough Drug Candidate
Altasciences recently completed an important First-in-Human (FIH), Phase I, integrated adaptive clinical trial, including single and multiple ascending doses (SAD and MAD), Project Management, Bioanalysis, and Medical Writing, for sponsor Bellus Health.
Altasciences Completes Bioanalytical Laboratory Expansion
Altasciences is excited to announce the completion of their laboratory expansion.
Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff
Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington.
Altasciences to present Continuing Education Course at the New York State Bar Association
Altasciences is pleased to announce that Dr. Graham K. Wood, Chief R&D Officer at Altasciences, is presenting at a Continuing Legal Education program entitled Practical Implications of Decriminalized Marijuana for the Legal Practitioner on Wednesday, October 3.
Dr. William J. Foster Joins Altasciences as Principal Investigator
Altasciences is pleased to welcome Dr. William J. Foster, MD, PhD, FRCSC, to the Altasciences family as Principal Investigator and Consultant on clinical trials.